First Time Loading...

Fusion Pharmaceuticals Inc
NASDAQ:FUSN

Watchlist Manager
Fusion Pharmaceuticals Inc Logo
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
Watchlist
Price: 21.4575 USD 0.03%
Updated: May 6, 2024

Fusion Pharmaceuticals Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Fusion Pharmaceuticals Inc
Revenue Peer Comparison

Comparables:
ZYME
TH
RPTX
AUPH
EDT

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
Revenue
$2.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zymeworks Inc
NYSE:ZYME
Revenue
$76m
CAGR 3-Years
25%
CAGR 5-Years
7%
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Revenue
$78.1m
CAGR 3-Years
6%
CAGR 5-Years
8%
CAGR 10-Years
27%
Repare Therapeutics Inc
NASDAQ:RPTX
Revenue
$51.1m
CAGR 3-Years
700%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Revenue
$175.5m
CAGR 3-Years
52%
CAGR 5-Years
223%
CAGR 10-Years
68%
Spectral Medical Inc
TSX:EDT
Revenue
CA$1.6m
CAGR 3-Years
-9%
CAGR 5-Years
-16%
CAGR 10-Years
-5%

See Also

What is Fusion Pharmaceuticals Inc's Revenue?
Revenue
2.1m USD

Based on the financial report for Dec 31, 2023, Fusion Pharmaceuticals Inc's Revenue amounts to 2.1m USD.

What is Fusion Pharmaceuticals Inc's Revenue growth rate?
Revenue CAGR 1Y
42%

Over the last year, the Revenue growth was 42%.